Only when we have tools to detect, treat and prevent coronavirus disease everywhere, will we be able to stop the pandemic. Developing these tools requires new global partnerships and cooperation.
Vaccines are one of our most powerful health tools. Here’s some of the lessons we’ve learned about the development and use of vaccines from past outbreaks.
By fully funding research and development for COVID-19 testing, treatment and vaccines we can reach COVID-Zero – no preventable deaths, no further lockdowns, no more disruption.
We’ve awarded £12 million, in partnership with DFID, to speed up global COVID-19 research and development and help low- and middle-income countries prepare. But more investment is needed.
We're making our headquarters on Euston Road available as an official respite centre for local NHS staff responding to the coronavirus pandemic.
Wellcome is supporting a step-change in COVID-19 testing by the UK government. Partners include the NHS, Public Health England, diagnostics companies Thermo Fisher Scientific, QIAGEN and Randox, UK universities, Boots, Royal Mail and Amazon.
The COVID-19 Therapeutics Accelerator is funding clinical trials that will answer whether the anti-malarial drugs hydroxychloroquine and chloroquine can be used to prevent the spread of COVID-19.
A vaccine for COVID-19 which uses cutting-edge RNA technology has entered phase 1 clinical trials. If successful, it could revolutionise the future of vaccine development.
Now is not the time to make cautious investments: now is the time for courageous action to tackle COVID-19.